AI in pharma state of play report 2026
Our second annual report, based on interviews with 20 pharma Insights Leaders, shows where AI access is turning into real commercial value.
Watch our latest webinar: Who can you trust? A pharma leader’s guide to vetting AI for insights
View NowOur thinking
Latest thought pieces and industry opinion
Our second annual report, based on interviews with 20 pharma Insights Leaders, shows where AI access is turning into real commercial value.
Our second annual report, based on interviews with 20 pharma Insights Leaders, shows where AI access is turning into real commercial value.
Plain-English definitions of the AI terms you'll hear in vendor pitches and proposals, so you can ask effective questions about AI.
Understand the three tiers of AI personas, when to use each and the questions to ask before you choose an AI vendor.
Our whitepaper shows how GenAI is reshaping clinician and patient decision journeys, and what your brand must do to stay visible and trusted.
Our survey of 500 clinicians across five specialisms reveals how GenAI is shaping diagnosis and prescribing, and what pharma should do now.
A one-page template to help your insights and analytics team turn AI ambition into a practical transformation roadmap.
Our vetted guide to the six GenAI tools we use and trust, with what each does best, limitations to watch and prompts to try today.